Itonis Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Mark Cheung
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.5yrs |
| CEO ownership | n/a |
| Management average tenure | 13.5yrs |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
No updates
CEO
Mark Cheung
13.5yrs
Tenure
Mr. Mark H. Cheung serves as Corporate Counsel and Director of Migranade, Inc. Mr. Cheung serves as Chief Executive Officer and President of Itonis Inc. since May 23, 2011. Mr. Cheung is an Adjunct Profess...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 13.5yrs | no data | no data | |
| CFO & Treasurer | 13.5yrs | no data | no data | |
| Chief Technology Officer | 12.5yrs | no data | no data | |
| President of Itonis Pharmaceuticals | no data | no data | no data |
13.5yrs
Average Tenure
Experienced Management: ITNS's management team is seasoned and experienced (13.5 years average tenure).